JMJD2B Promotes Epithelial–Mesenchymal Transition by Cooperating with β-Catenin and Enhances Gastric Cancer Metastasis
Open Access
- 1 December 2013
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 19 (23), 6419-6429
- https://doi.org/10.1158/1078-0432.ccr-13-0254
Abstract
Purpose: This study investigated the role of histone demethylase Jumonji domain–containing protein 2B (JMJD2B) in promoting epithelial–mesenchymal transition (EMT) and underlying molecular mechanisms in the progression of gastric cancer. Experimental Design: The induction of EMT by JMJD2B in gastric cancer cells and its underlying mechanisms were examined by a series of assays. In vivo and in vitro assays were performed to clarify invasive potential of JMJD2B in gastric cancer cells. The expression dynamics of JMJD2B were detected using immunohistochemistry in 101 cases of primary gastric cancer tissues. Results: Inhibition of JMJD2B by specific siRNA suppresses EMT of gastric cancer cells, whereas ectopic expression of JMJD2B induces EMT. Importantly, JMJD2B is physically associated with β-catenin and enhances its nuclear localization and transcriptional activity. JMJD2B, together with β-catenin, binds to the promoter of the β-catenin target gene vimentin to increase its transcription by inducing H3K9 demethylation locally. JMJD2B inhibition attenuates migration and invasion of gastric cancer cells in vitro and metastasis in vivo. The expression of JMJD2B was positively correlated with tumor size (P = 0.017), differentiation status (P = 0.002), tumor invasion (P = 0.045), lymph node metastasis (P = 0.000), distant metastasis (P = 0.024), and tumor–node–metastasis (TNM) stage (P = 0.002) in patients with gastric cancer. Conclusions: The data reveal a novel function of JMJD2B in promoting EMT and gastric cancer invasion and metastasis, implicating JMJD2B as a potential target for reversing EMT and intervention of the progression of gastric cancer. Clin Cancer Res; 19(23); 6419–29. ©2013 AACR.Keywords
Other Versions
This publication has 44 references indexed in Scilit:
- SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activitiesThe EMBO Journal, 2011
- Vimentin in cancer and its potential as a molecular target for cancer therapyCellular and Molecular Life Sciences, 2011
- Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesisProceedings of the National Academy of Sciences of the United States of America, 2011
- Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancerMolecular Cancer, 2010
- Epithelial-mesenchymal transitions and hepatocarcinogenesisJCI Insight, 2010
- Novel Oligoamine Analogues Inhibit Lysine-Specific Demethylase 1 and Induce Reexpression of Epigenetically Silenced GenesClinical Cancer Research, 2009
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Snail and Slug Promote Epithelial-Mesenchymal Transition through β-Catenin–T-Cell Factor-4-dependent Expression of Transforming Growth Factor-β3Molecular Biology of the Cell, 2008
- Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patientsGut, 2006
- Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cellsGenes & Development, 2006